Health

The medical data aggregator increased its overall funding from $95m to $200m and has secured three new health system patners.

Deep Nishar has departed from his SBIA senior managing partner role to help develop enterprise software, biotech and life sciences pipelines at the venture firm.

Alexandria Venture Investments was among the participants in a series B round which will support clinical trials for Acrivon's lead oncology drug candidate.

The venture firm has hired Jayson Punwani a year after he left his partner position at corporate venturing unit Takeda Ventures.

Existing investors Lilly Asia Ventures and SBCVC returned for the multiomics product developer's latest round, in which it raised nearly $100m.

Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis eyecare subsidiary Alcon has agreed to acquire the Institut Mérieux, Ascension Health and MemorialCare Health System-backed MIGS technology provider.

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Vertex Pharmaceuticals and Illumina Ventures both contributed to a round that increased the genetic therapeutics developer's total funding to over $300m.

Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the Institut Curie spinout.